Enzymatica publ AB Strategic Asset Allocation Index
Enzymatica publ AB strategic asset allocation index. Enzymatica publ AB (ENZY) has a Strategic Asset Allocation Index of 8.6% as of September 2025. Strategic assets (PP&E of Skr11.70 Million plus long-term investments of Skr-) total Skr11.70 Million, measured against net assets of Skr135.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See ENZY equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Enzymatica publ AB (2007–2024)
Strategic asset allocation index of Enzymatica publ AB from 2007 to 2024. This chart shows how Enzymatica publ AB's Strategic Asset Allocation Index has evolved across 16 annual periods from 2007 to 2024. As of September 2025, the index stands at 8.6%, representing strategic assets of Skr11.70 Million against net assets of Skr135.68 Million SEK. Check Enzymatica publ AB tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Enzymatica publ AB Strategic Asset Allocation Index by Year (2007–2024)
Enzymatica publ AB strategic asset allocation index by year from 2007 to 2024. The table below presents the year-by-year Strategic Asset Allocation Index for Enzymatica publ AB from 2007 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see ENZY market cap.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 8.2% | Skr14.40 Million | Skr14.40 Million | Skr- | Skr176.37 Million | ▼ -13.4 pp |
| 2023 | 21.5% | Skr16.48 Million | Skr16.48 Million | Skr- | Skr76.61 Million | ▲ +8.5 pp |
| 2022 | 13.0% | Skr16.40 Million | Skr16.40 Million | Skr- | Skr126.29 Million | ▲ +0.9 pp |
| 2021 | 12.1% | Skr15.16 Million | Skr15.16 Million | Skr- | Skr124.97 Million | ▲ +2.5 pp |
| 2020 | 9.6% | Skr10.26 Million | Skr10.26 Million | Skr- | Skr106.65 Million | ▲ +2.1 pp |
| 2019 | 7.5% | Skr8.95 Million | Skr6.78 Million | Skr2.17 Million | Skr119.20 Million | ▲ +3.9 pp |
| 2018 | 3.6% | Skr5.77 Million | Skr4.54 Million | Skr1.24 Million | Skr159.66 Million | ▼ -0.8 pp |
| 2017 | 4.4% | Skr4.89 Million | Skr4.87 Million | Skr23.00K | Skr110.70 Million | ▲ +1.3 pp |
| 2016 | 3.1% | Skr4.40 Million | Skr4.38 Million | Skr23.00K | Skr142.04 Million | ▲ +1.8 pp |
| 2015 | 1.3% | Skr276.00K | Skr276.00K | Skr- | Skr21.98 Million | ▲ +0.8 pp |
| 2014 | 0.5% | Skr303.00K | Skr303.00K | Skr- | Skr62.42 Million | ▼ -0.9 pp |
| 2013 | 1.4% | Skr220.00K | Skr220.00K | Skr- | Skr15.73 Million | ▲ +1.3 pp |
| 2012 | 0.1% | Skr17.00K | Skr17.00K | Skr- | Skr14.06 Million | ▼ -0.6 pp |
| 2011 | 0.8% | Skr25.00K | Skr25.00K | Skr- | Skr3.31 Million | ▲ +0.4 pp |
| 2010 | 0.3% | Skr15.00K | Skr15.00K | Skr- | Skr4.40 Million | ▼ -20.8 pp |
| 2007 | 21.2% | Skr11.00K | Skr11.00K | Skr- | Skr52.00K | — |